The treatment of nasopharyngeal cancer with positive Epstein-Barr virus is still based on radiotherapy alone (early stage disease) or radiation therapy combined chemotherapy (later stage), but Epstein-Barr virus load is related to prognostic factor, emerging immunotherapy has had promising results.